Search filters

Filters
Clear All

Phase

  • 1
  • 48
  • 42
  • 34
  • 11
  • 113
  • 342
  • 178
  • 7
  • 14
  • 3
  • 320

Found 344 Barrett's Esophagus trials

A listing of Barrett's Esophagus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

1 years - 1 years
All genders
This project develops a SmarToyGym where sensorized, wireless toys are placed within the reach of infants to elicit body, arm/hand and leg movements. The objective is to conduct pilot testing of the SmartToyGm with atypical and typical infants. A battery of metrics will be identified to discriminate between high and …
 PD GPI MRFGUS
30 years - 100 years
All genders
To demonstrate ExAblate procedure is safe and works.There is evidence in medical literature showing that by ablating a particular cluster of cells in the brain, dyskinesia (abnormal movements)&motor symptoms of PD may improve. ExAblate can be used to perform ablation more precisely in minimally invasive fashion. In this study we …
 Study to Evaluate the Safety and Efficacy of Upadacitinib in Giant Cell Arteritis: SELECT-GCA
50 years - 100 years
All genders
Phase 3
The main purpose of this study is to understand how well giant cell arteritis (also known as temporal arteritis; GCA) responds to an investigational drug called upadacitinib. Upadacitinib is being tested to find out if it is safe and effective in treating GCA. An investigational drug is one that is …
 World-wide Randomization Antibiotic Envelope Infection Prevention Trial (WRAP-IT)
1 years - 100 years
All genders
This study is a single-blinded,randomized,prospective, multi-center clinical trial. The study will evaluate the ability of the TYRX absorable Antibacterial Envelope to reduce major cardiovascular implantable electronic device (CIED) infections. Patients undergoing CIED generator replacement, upgrade, revision or new biventricular defibrillator system will be randomized to receive the TYRX envelope or …
 HCMR  Novel Predictors of Outcome in Hypertrophic Cardiomyopathy
1 years - 99 years
All genders
The Specific Aim of this study is to develop a predictive model of cardiovascular outcomes in hypertrophic cardiomyopathy (HCM) by: 1) using exploratory data mining methods to identify demographic, clinical, and novel cardiac magnetic resonance imaging, genetic and biomarker variables associated with the outcomes and 2) develop a score from …
 A Randomized, Double-blind, Active-controlled Trial to Assess the Efficacy and Safety of AXS-05 Administered Orally to Subjects with Treatment Resistant Major Depressive Disorder
18 years - 65 years
All genders
We are currently enrolling participants for a clinical research study to look at the effectiveness and safety of an investigational medication AXS-05 (a combination of bupropion and dextromethorphan) compared to bupropion (Approved by FDA), in patients with depression who have not responded to prior treatment with at least one antidepressant. …
 Telemedicine vs in-person delivery of cognitive behavioral treatment of insomnia: a mixed methods analysis
21 years - 60 years
All genders
Cognitive behavioral therapy for insomnia (CBT-I) has been the gold standard for the treatment of insomnia. There is a need to increase access to treatment, particularly for patients in more rural locations where providers may be scarce. One solution is to utilize telemedicine which is 'the use of electronic communications …
18 years - 70 years
Male
Phase 3
Phase 1 will enroll 10 healthy participants. We will use remote sensors worn on the wrist and waist to collect data on personal exposure to air pollutants and check your physical functioning over approximately 48 hours in this 3 Phase study. This will build an understanding on which types of …
 DEPRESSION STUDY: INVESTIGATING LINKS BETWEEN SLEEP AND MOOD
25 years - 50 years
Female
GOAL: This research study aims to examine the role of slow-wave sleep activity in improving mood in individuals with Major Depressive Disorder (MDD).TARGET POPULATION: We are looking for 40 currently depressed males and females and 20 healthy controls with no history of depression between the ages of 25-50. Participants must …
 Phase 1 Open-Label Study to Determine the Safety and Tolerability of AVID200, a Transforming Growth Factor B Inhibitor, in Diffuse Cutaneous Systemic Sclerosis
18 years - 90 years
All genders
Phase 1
This study is being done to learn more about the safety of the study drug, AVID200, and to find out more about the effects of different study drug doses in people with scleroderma.  AVID200 is referred to as an investigational drug because it is in the early stages of development …
21 - 30 of 344